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Abstract
Introduction: Triploid pregnancies have an increased risk of early preeclampsia. Twin pregnancies
consisting of one healthy fetus and one complete or partial molar, with or without a triploid fetus, are
rare and management is complex.
Case presentation: A 33-year-old Caucasian woman presented with a dichorionic diamniotic twin
pregnancy. One fetus showed early growth restriction resulting in fetal death at 20 weeks. The
placenta was enlarged with some cysts. Chorionic villus biopsy confirmed triploidy. At 21 weeks, the
patient developed preeclampsia with a blood pressure of 154/98 mmHg and proteinuria (24 hour
protein excretion of 2.5 g/L), for which she was hospitalized. Without pharmacological interventions,
the blood pressure normalized and proteinuria disappeared. At 35 weeks, she again developed
preeclampsia. A cesarean section was performed at 38 weeks and a healthy child was born.
Conclusions: Survival of the healthy fetus is possible in a twin pregnancy with a triploid fetus
complicated by early preeclampsia. The pregnancy should not be terminated if the triploid twin has
died and as long as conservative management is safe.
Introduction
Triploidy is a genetic disorder with an extra haploid set of
chromosomes resulting in a total of 69 chromosomes. Two
types of triploidy can be distinguished according to the
parental origin [1]. Type I, with the additional chromosome
set being of paternal origin (diandric), is consistent with
normal growth of the fetus, with increased nuchal
translucency, and an enlarged and partially multicystic
placenta with elevated levels of maternal serumbeta human
chorionic gonadotropin (b-hCG). Partial molar gestations
are usually associated with triploidy of diandric origin.
Type II, with the additional chromosome set being of
maternal origin (digynic), is characterized by a small but
normal placenta with decreased levels of b-hCG and
asymmetrical fetal growth restriction. Common structural
defects in both types are malformed hands, head, heart
and face [2].
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Triploid pregnancies rarely advance into the second
trimester, but if they do, a high risk of early onset severe
preeclampsia is noticed as a result of the molar tissue of
type I triploidy. In a series of 17 triploid pregnancies, six
cases (35%) developed early preeclampsia or hypertension
[3]. Elevated serum b-hCG levels and placentomegaly were
associated with a higher risk of preeclampsia but with low
levels of b-hCG, there was no association.
Twin pregnancies consisting of one healthy fetus and one
complete or partial molar, with or without a triploid fetus,
are rare. The molar tissue can provoke early preeclampsia,
heavy vaginal bleeding and persistent gestational tropho-
blastic disease (pGTD). Experiences with partial molar
twin pregnancies are limited. Only five cases of a triploid
fetus and a healthy co-twin have been reported [4-8]. Of
these five cases, two co-twins survived after selective
abortion of the triploid fetus. In a large series of 77
complete molar twin pregnancies, 40% successful out-
come for the healthy co-twin was reported for parents who
wished to continue their pregnancy [9]. Neither serious
obstetric complications nor an increase in development
of pGTD was noticed. Three pregnancies were terminated
because of preeclampsia.
Partial molar pregnancies are rarely associated with
persistent or metastatic disease, but early preeclampsia is
often reported. In three cases [4-6] of five concerning a
triploid fetus and a healthy co-twin, a therapeutic abortion
was performed, two of which were for severe preeclampsia.
There are only two cases reported with survival of the
healthy co-twin, both after selective abortion of the
triploid fetus. One healthy co-twin was born after
27 weeks’ gestation and the other after 38 weeks’ gestation
[7,8].
Preeclampsia can occur even after the triploid fetus has
died. Nugent [4] reported a case where selective termina-
tion of the triploid twin was performed at 15 weeks’
gestation. At 19 weeks, severe preeclampsia developed,
necessitating therapeutic abortion.
We present the first reported patient with triploid twin
pregnancy with a successful outcome for the healthy
co-twin after early transient preeclampsia.
Case presentation
A 33-year-old Caucasian woman, gravida 3, para 1, was
admitted to our clinic. Her obstetric history mentioned a
miscarriage and a pregnancy complicated by intrauterine
growth restriction, without signs of preeclampsia. At 37
weeks’ gestation, cesarean section was performed because
of fetal distress. A boy was delivered, weighing 2015 g,
with Apgar scores of 9 and 10 at one and five minutes,
respectively. Histology of the placenta revealed 10%
infarctions and a thrombus in the umbilical cord. Blood
analysis after three months showed no hemostatic
abnormalities associated with an increased risk of
thrombosis.
Ultrasound examination of the index pregnancy at 112
weeks’ gestation showed a dichorionic diamniotic twin
pregnancy with measurements consistent with gestational
age. The Crown Rump Lengths were 39 mm, consistent
with 106 weeks, and 45 mm, consistent with 112 weeks.
Nuchal translucency thickness measurements were not
performed. No abnormalities of the placenta were
documented.
Her blood pressure was 125/70 mmHg. The pregnancy
was complicated by episodes of vaginal bleeding at
16 weeks’ gestation. Ultrasound showed one fetus with
normal growth and one with early growth restriction and
measurements consistent with 13 weeks. An echogenic
area was interpreted as blood clots. At 20 weeks’ gestation,
fetal death of the abnormal fetus was noticed. One week
later, the patient was asymptomatic but her blood pressure
increased (154/98) which prompted the suspicion of a
partial molar pregnancy. An enlarged placenta of 10 cm ×
12 cmwith some cysts was prominent on the anterior wall.
Blood flow had ceased in this placenta. Urinary protein
excretion was 2.5 g/L. Maternal serum beta-human-
chorionic-gonadotropin (b-hCG) was markedly raised:
423,000 IU/L. Other laboratory investigations were
normal.
The patient was sent to a University Hospital because of
early preeclampsia and suspicion of a triploid twin. We
decided to perform a chorionic villous biopsy because the
placenta of the dead fetus was on the anterior wall. We did
not perform a chorionic villous biopsy of the placenta of
the healthy twin because no abnormalities were noticed by
ultrasound and the placenta was located on the posterior
wall.
Chorionic villus biopsy confirmed triploidy, 69, XXY.
Without pharmacological interventions, the blood pres-
sure stabilized, proteinuria decreased, and b-hCG
decreased to 222,835 IU/L. At 22 weeks, the patient was
discharged. She was reviewed twice a week. Urinary
protein excretion was positive until 23 weeks, and blood
pressure slowly decreased and normalized at 30 weeks.
The b-hCG further decreased to 27,600 IU/L at 33 weeks.
Episodes of some vaginal bleeding and cramps occurred
up to 28 weeks’ gestation. The placenta of the triploid twin
was still enlarged until 23 weeks: 8 cm × 12 cm (Figure 1).
At 35 weeks, the patient developed preeclampsia again
and was hospitalized. Her blood pressure increased to
170/105 mmHg and proteinuria to 0.8 g/L. Methyldopa
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3 × 250 mg was initiated to control the blood pressure
with good result (Figure 2). Blood analysis showed no
signs of hemolysis, elevated liver enzymes, low platelets
(HELLP) syndrome. At 38 weeks, a cesarean section was
performed for fetal distress. A healthy girl weighing 2,710
g was born with Apgar scores of 9 and 10 at one and five
minutes, respectively. The placenta of the triploid fetus
was necrotic and as a result of autolysis, no further
histologic information on fetus and placenta were avail-
able. b-hCG follow-up showed no signs of persistent
gestational trophoblastic disease (pGTD). Four days after
delivery, the level had already decreased to 440 IU/L.
Discussion
We present the first reported patient with transient
preeclampsia in a twin pregnancy with a triploid fetus.
In our patient, placentomegaly and high levels of b-hCG
accompanied the development of preeclampsia. This is
consistent with the reported series of Rijhsinghani et al. [3]
and two other case reports of triploid twin pregnancies
complicated by preeclampsia [4,6].
The presentation of the triploid fetus is not consistent with
the two types of triploidy. Placentomegaly and preeclamp-
sia are characteristics of type I triploidy, whereas growth
restriction is a type II characteristic. The finding of growth
restriction in a type I triploidy seems atypical but has been
reported [10]. Rijsinghani et al. reported seven patients
with triploid pregnancies who became preeclamptic. Four
of them showed fetal growth restriction. The combination
of growth restriction and preeclampsia in a triploid
pregnancy does not seem to be uncommon. We believe
growth restriction is not a specific type II characteristic.
Another interesting point is the possibility of selective
abortion to improve the outcome for the healthy fetus.
In retrospect, we should have considered karyotyping at
16 weeks’ gestation, when intrauterine growth restriction
of three weeks was noted in one fetus. After the result of
triploidy, we could have subsequently offered selective
abortion. In our patient, the natural death of the triploid
fetus at 20 weeks undoubtedly rescued the remaining
healthy fetus. Regression of preeclampsia has been
reported in twin pregnancies with early preeclampsia
linked to a lethal condition in one twin, and in which
selective abortion was performed [11].
Early selective abortion of the triploid twin, at least before
20 weeks, is not only indicated to prevent preeclampsia
but also to decrease the preterm delivery risk for the
remaining fetus [12]. Two cases of successful outcome for
the normal co-twin in a triploid twin pregnancy have been
reported [7,8]. In both cases, selective abortion of the
triploid fetus was performed.
Conclusion
This case shows that, after the death of the triploid twin,
the partial molar placenta can still cause preeclampsia, but
the preeclampsia can regress. We conclude that, in the case
of a twin pregnancy with a triploid fetus and early
preeclampsia, there is no need for early termination of
the pregnancy. As long as the preeclampsia is stable,
successful outcome for the healthy co-twin is possible. If
the triploid fetus is still alive, selective abortion may be
offered.
Figure 1. Placenta at 23 weeks.
Figure 2. Graphic analysis of the mean arterial blood
pressure (mmHg) and proteinuria (g/24 hours). Urine protein
stick was negative after 23 weeks. Left axis, mean arterial
pressure (mmHg); right axis, proteinuria (g/L); horizontal axis,
gestational age; hatched fill, proteinuria g/L; filled triangles,
MAP (mean arterial pressure mmHg); arrow, start of
methyl-dopa 3 × 250 mg.
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